rhein-8-glucoside

rhein-8-glucoside
Name	Rhein-8-glucoside
Othernames	Rhein 8-O-β-D-glucopyranoside

rhein-8-glucoside is an anthraquinone glycoside derived from the aglycone rhein, found in several plant-derived traditional remedies and modern phytochemical studies. It is of interest across pharmacology, natural product chemistry, and medicinal chemistry for its reported bioactivities and distinct glycosidic linkage at the C-8 position. Research on the compound connects laboratories and institutions studying phytochemistry, ethnopharmacology, and drug discovery.

Chemical structure and nomenclature

Rhein-8-glucoside is systematically described as rhein 8-O-β-D-glucopyranoside and belongs to the class of anthraquinone glycosides; its structure comprises an anthraquinone core analogous to rhein with a β-D-glucose moiety attached at the C-8 hydroxyl via an O-glycosidic bond. Structural description references conventions used by the International Union of Pure and Applied Chemistry and naming schemes applied in publications from institutions such as Royal Society of Chemistry and American Chemical Society. The molecule can be compared to other anthraquinone glycosides like emodin-8-glucoside and chrysophanol derivatives characterized in monographs from collections curated by museums such as the Natural History Museum, London.

Natural sources and occurrence

Rhein-8-glucoside occurs in the roots, rhizomes, and barks of several plants used in traditional systems, notably species within the genera Rheum and Cassia historically cataloged by herbaria including the Kew Gardens and studied by researchers at the Smithsonian Institution. Ethnobotanical surveys linking the compound to medicinal preparations are reported from regions associated with institutions such as the Chinese Academy of Sciences, the University of Tokyo, and universities in India and Germany. Herbal materia medica texts curated by the British Museum and botanical treatises at the Bibliothèque nationale de France provide context for the occurrence of related anthraquinones in traditional remedies.

Biosynthesis and enzymatic formation

Biosynthetic pathways for anthraquinone glycosides involve polyketide synthase-derived anthraquinone cores and subsequent glycosylation by UDP-glucosyltransferases; analogous enzymology has been characterized by research groups at the Max Planck Society, Harvard University, and the John Innes Centre. Enzymes responsible for O-glycosylation at the C-8 position are mechanistically similar to glycosyltransferases studied in the context of flavonoid and saponin biosynthesis at institutions such as the European Molecular Biology Laboratory and the Salk Institute. Comparative genomics studies hosted by consortia including the National Center for Biotechnology Information and European Bioinformatics Institute aid annotation of candidate genes in medicinal plant genomes that produce rhein-type metabolites.

Physicochemical properties

As an anthraquinone glycoside, rhein-8-glucoside displays UV-visible absorbance characteristics comparable to anthraquinone chromophores cataloged in standards from the National Institute of Standards and Technology and solubility behavior influenced by its polar glucose substituent, a property exploited in chromatographic separations developed at facilities like the University of California, Berkeley and ETH Zurich. Thermal and stability profiles are assessed using methodologies standardized by organizations such as ASTM International and analytical platforms from manufacturers like Agilent Technologies and Waters Corporation.

Biological activities and pharmacology

Rhein-8-glucoside has been evaluated for bioactivities that mirror those attributed to rhein and related anthraquinones in studies conducted at the World Health Organization-affiliated research centers and university laboratories including Peking University and University of Oxford. Reported activities include anti-inflammatory, laxative, and antimicrobial effects explored in preclinical models by research groups at the National Institutes of Health and Karolinska Institutet. Pharmacokinetic and metabolism investigations consider glycoside hydrolysis, conjugation, and enterohepatic processing pathways described in reviews from the Food and Drug Administration and regulatory pharmacology divisions at the European Medicines Agency.

Methods of isolation and synthesis

Isolation of rhein-8-glucoside from plant matrices typically employs solvent extraction, partitioning, and chromatographic purification using techniques refined in chemistry departments at University of Cambridge, Columbia University, and University of Toronto. Synthetic approaches include chemical glycosylation of rhein using activated sugar donors and enzymatic transfer using glycosyltransferases expressed in systems developed at the Massachusetts Institute of Technology and Wageningen University. Protocols align with best practices disseminated by publishers such as Springer Nature and Elsevier in peer-reviewed methods papers.

Analytical detection and quantification

Detection and quantification rely on hyphenated techniques like high-performance liquid chromatography coupled to mass spectrometry (HPLC-MS/MS) and nuclear magnetic resonance spectroscopy (NMR), with method validation frameworks drawn from standards by the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use and analytical laboratories at GlaxoSmithKline and Pfizer. Databases curated by the ChemSpider and spectral libraries at the Royal Society of Chemistry support structure confirmation, while metabolomics platforms at centers such as the European Molecular Biology Laboratory facilitate profiling in complex biological samples.

Category:Anthraquinone glycosides